A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
What the source said
“A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial”
For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications, while traditional craniotomy resection surgery often carries the risk of irreversible neurological...
Read at South China Morning Post – ChinaReported by one source so far. It is confirmed when a second, independent source reports the same thing.